CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Revenues	$ 3,524,331	$ 2,486,896
Cost of goods sold	330,188	289,340
Gross profit	3,194,143	2,197,556
Operating expenses
Selling, general and administrative expense	4,906,538	2,350,363
Depreciation and amortization	53,505	4,340
Bad debt expense	30,000	0
Total operating expenses	4,990,043	2,354,703
Operating income (loss)	(1,795,900)	(157,147)
Other expense
Other expense	(36,758)	0
Interest expense	(8,354)	(5,425)
Total other expense	(45,112)	(5,425)
Net loss	(1,841,012)	(162,572)
Less: net loss attributable to noncontrolling interest	(4,055)	0
Net loss attributable to Sanara MedTech common shareholders	$ (1,836,957)	$ (162,572)
Basic income per share of common stock	$ (0.39)	$ (0.39)
Diluted income per share of common Stock	$ (0.39)	$ (0.39)
Weighted average number of common shares outstanding basic	4,751,941	420,698
Weighted average number of common shares outstanding diluted	4,751,941	420,698